 Eiger BioPharmaceuticals, Inc. NASDAQ:EIGR Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Sarah Mathieson - Senior Vice President, Corporate Affairs David Cory - President and CEO Sri Ryali - Chief Financial Officer Eldon Mayer - Chief Commercial Officer Ingrid Choong - Senior Vice President, Clinical Development Colin Hislop - Senior Vice President, Clinical Development Operations Colleen Craig - Vice President, Metabolic Diseases Conference Call Participants Maury Raycroft - Jefferies Charlie Moore - Baird Bert Hazlett - BTIG Farhana Sakloth - Ladenburg Operator Welcome to the Eiger BioPharmaceuticals Third Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. 